site stats

Alfasigma clinical trials

Web05 May 2024 Phase-III clinical trials in Venous insufficiency in Slovakia (PO, Capsule) (EudraCT2024-000110-15) 14 Apr 2024 Phase-III development for Venous insufficiency … WebSep 22, 2024 · "Alfasigma is a forward-thinking sponsor modernizing clinical operations to drive better collaboration with CROs," said Pinar Berenice Benet, senior director …

Phesi Collaborates with Alfasigma on Digital Transformation …

WebALFASIGMA ACQUIRES THE ENTIRE SHARE CAPITAL OF SOFAR, AN ITALIAN PHARMACEUTICAL COMPANY. The acquisition process, already announced last … WebPhesi and Alfasigma are currently working together to maximize the value of priority medical assets, explore the use of synthetic data, and apply advanced analytics to … pin synonim https://intersect-web.com

Salix And Alfasigma Will Initiate Late-Stage Program To Study …

WebJul 8, 2024 · Alfasigma USA has acquired the brand ZELNORM (tegaserod), a treatment for IBS-C, from Sloan Pharma, with the aim to relaunch the brand in the United States ... The evaluation consisted of a review of the clinical data from 29 placebo-controlled trials and post-marketing treatment outcomes data. WebInnovation. fueled by Passion. While supporting existing assets and developing new indications to address unmet needs, our Research & Development Department is … pin symbolism

Efficacy and safety of a new vaginal gel for the treatment …

Category:Alfasigma Italy - ResearchGate

Tags:Alfasigma clinical trials

Alfasigma clinical trials

Salix And Alfasigma Will Initiate Late-Stage Program To Study …

WebNov 27, 2024 · This is the first phase 3 clinical trial of fidaxomicin treatment for CDI in patients <18 years of age. Fidaxomicin was well tolerated in this age group: the proportions of patients with TEAEs were similar in the fidaxomicin and vancomycin arms, whereas some TEAEs (such as pyrexia, abdominal pain, and diarrhea) seemed less frequent with ... WebJun 22, 2024 · PhaseBio initiated the REVERSE-IT trial, a pivotal Phase 3 clinical trial of bentracimab, in March 2024 to support a Biologics License Application for bentracimab in both major bleeding and urgent ...

Alfasigma clinical trials

Did you know?

WebFind 56 researchers working at Alfasigma Italy WebSep 12, 2024 · John Kincaid, head of medical affairs at Alfasigma USA, said the safety trials showed that less than 1% of patients who received the drug in clinical trials had a cardiovascular problem. There was also no major MACE in the data from patients who had the preexisting conditions for cardiovascular issues, he added.

WebClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. Explore 448,545 research studies in all 50 states and in 221 countries. See listed clinical studies related to the coronavirus disease (COVID-19) WebThe present single-center randomized clinical trial demonstrated the efficacy, tolerability and safety of 12-week treatment with a new vaginal gel in postmenopausal women with …

WebAlfasigma USA, Inc. Brand Direct Health ®; Contact Us; DEPLIN ® is a prescription medical food for use only under the supervision of a physician for the clinical dietary management of depression and is specially … WebChief Executive Officer at Alfasigma. “The Phase 2 Brilacidin clinical study results in UP/UPS ... open-label, Proof-of-Concept (PoC) clinical trial evaluating Brilacidin for UP/UPS. In addition, mucosal healing was evidenced by endoscopic review, an increasingly important measure toward establishing a drug’s efficacy. In late 2024, the

WebJul 8, 2024 · Alfasigma USA, Inc. is the American affiliate of Alfasigma, a leading Italian pharmaceutical company. Alfasigma is present in more than 90 countries, with a workforce of around 3,000 people and 5 ...

WebMar 28, 2024 · 15 Mar 2024 Innovation Pharmaceuticals plans preclinical trials for Mycoses ; 28 Feb 2024 No recent reports of development identified for phase-I development in … pin sylvestre pinus sylvestrisWeb"The amended agreement with Alfasigma allows us to start working together on a clinical research program that could lead to a new option in the treatment paradigm for postoperative Crohn's disease patients." The new formulation of rifaximin, called Extended Intestinal Release (EIR), will be used in the late-stage clinical research program. pin's yslWebPhesi and Alfasigma are currently working together to maximize the value of priority medical assets, explore the use of synthetic data, and apply advanced analytics to protocol design and investigator site selection. To support protocol design, performance-based investigator selection, and patient enrollment in clinical trials, Phesi provides ... haines junction yukon lodgingWebThe present single-center randomized clinical trial demonstrated the efficacy, tolerability and safety of 12-week treatment with a new vaginal gel in postmenopausal women with symptoms associated with VVA. ... Alfasigma) in the treatment of vulvovaginal atrophy (VVA). The gel is composed of sea buckthorn (Hippophaë rhamnoides) oil, aloe vera ... haines kansasWebApr 14, 2024 · V.S. reports research funding from Novartis to conduct clinical trials; other grant support for clinical trials from AbbVie, Agensys, Alfasigma, Altum, Amgen, Bayer, BERG Health, Blueprint ... haine ski copiiWebJul 20, 2024 · Alfasigma Accelerating Clinical Trials with Veeva Vault Clinical Applications Italian pharmaceutical company will use Vault CTMS and Vault eTMF to improve study efficiency and speed the delivery of new therapies to patients BARCELONA, Spain, Sept. 22, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that … haine skateWebClinical Trials. US Clinical Trials Registry; EU Clinical Trials Registry; Pharmaceutical Companies; Clinical Research Labs ... Advanced search; Show all trials; Glossary; … pin system kodi